Boundless Bio (BOLD) vs Gossamer Bio (GOSS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Boundless Bio (BOLD) has outperformed Gossamer Bio (GOSS) over the past year, gaining 114.6% versus a loss of 94.9%. Gossamer Bio is the larger company by market cap ($61.9 million vs $59.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BOLD | GOSS |
|---|---|---|
| Share price | $2.63 | $10.12 |
| Market cap | $59.83M | $61.90M |
| 1-day change | -0.38% | -0.59% |
| YTD return | +120.00% | -95.90% |
| 1-year return | +114.63% | -94.91% |
| 5-year return | — | -99.10% |
| EPS (TTM) | $-2.85 | $-52.80 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.16 | $309.60 |
| 52-week low | $0.961 | $9.12 |
| Distance from 52-week high | -16.88% | -96.73% |
| Average volume | 179.14K | 377.00K |
| Shares outstanding | 22.75M | 6.12M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BOLD has outperformed GOSS by 209.5 percentage points over the past year.
BOLD vs GOSS FAQ
Which is bigger, Boundless Bio or Gossamer Bio?
Gossamer Bio (GOSS) is larger, with a market capitalization of $61.90M compared with $59.83M for Boundless Bio (BOLD).
Which stock has performed better over the past year, BOLD or GOSS?
BOLD returned +114.63% over the past 12 months, compared with -94.91% for GOSS (price return, excluding dividends). Past performance does not predict future results.
Are Boundless Bio and Gossamer Bio in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.